Introducing a technological
revolution in digital medical diagnostics

Our minimally invasive technology addresses a number of disease state diagnostics including allergy testing, pain-free automated glucose monitoring, blood coagulation testing, tuberculosis (TB) testing and cholesterol monitoring.

The new age of digital electronic medical records (EMR) is here. SensiVida’s electro-optical diagnostic products will report directly to EMR’s with great accuracy and efficiency.This technological achievement in medical information management will make medical practice and health management more accurate,effective and efficient.

SensiVida also intends to develop "Molecular Optical Biopsy" medical devices that detect cancer using frequencies of light to distinguish cancer from normal tissues.

Click to play video


September 8, 2009

Letter to shareholders from CEO Kamal Sarbadhikari

More »
August 6, 2009

Mediscience Technology Corporation Completes Acquisition Of SensiVida Medical Systems, Inc. Merged Entity Is SENSIVIDA MEDICAL TECHNOLOGIES, INC. With New Board And CEO – CTO Management, Team

More »
July 28, 2009

MEDISCIENCE TECHNOLOGY CORP Files SEC Form 8-K, Entry Into A Material Definitive Agreement, Unregistered Sale Of Equity

More »